Prostate Cancer Screening Rates Lower With Advanced Cancers
According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise...
ICR Researchers Examine How New Medications Affect Cancer
Researchers discovered that by turning off the function of two genes, stomach tumours can become resistant to ATR inhibitors. As a result, genetic screening...
NHS To Provide Brain Laser Therapy To Those With Epilepsy
The NHS has made public its intentions to provide an avant-garde laser therapy for patients with epilepsy who have not previously responded well to...
HIV Patients Avoid hepatitis B With A Three-Dose Vaccine
A three-dose series of the HEPLISAV-B vaccine protects against hepatitis B virus (HBV) in HIV patients who have not received a prior vaccination against...
Latest Study By ICR Tracks Rare Childhood Cancer Progression
The researchers discovered that liquid biopsy blood tests may detect symptoms of a malignancy that has reappeared, evaluate the severity of the condition, and...
Merck And Moderna Sign $250mn Partnership For Cancer Vaccine
On October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the US and Canada, had chosen to use its $250...
Researchers At Stanford Create A Novel Cancer Treatment
The molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from Stanford University in the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...